Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Behavioral Activation for treating Bipolar Depression

Official title: Adjunctive Behavioural Activation for Bipolar Depression: A Case Series (BA-BD)

Run by Reykjavik University · NCT06022913 · Data updated 2026-11-12

This study is testing a new therapy called Behavioral Activation to see if it can help people with Bipolar Disorder who are feeling depressed by encouraging healthier activities and better sleep.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment10 (estimated)
SponsorReykjavik University
Academic / other
Locations1 site (Reykjavik)
StatusRecruiting
StartedNovember 22, 2023
Main results expectedDecember 31, 2025
Study endsDecember 31, 2025
Registry record updatedApril 16, 2025
Trial IDNCT06022913 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals diagnosed with Bipolar I or II Disorder who are currently experiencing depressive episodes.

Probably not a fit

Patients with current or past learning disabilities, severe substance dependence, or those at marked risk of self-harm may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to implement Behavioral Activation (BA) therapy for individuals experiencing depression associated with Bipolar Disorder (BD). BA is a therapeutic approach that focuses on helping patients re-establish healthier activity patterns and improve sleep regulation, which is crucial for mood stabilization in BD. The research will assess the feasibility of BA for this specific patient group, as there is limited existing research on its effectiveness for bipolar depression. Participants will be evaluated based on their depression severity and must meet specific diagnostic criteria for Bipolar I or II Disorder.

Why it matters

Potential benefit: If successful, this approach could provide an effective therapeutic option for managing depression in patients with Bipolar Disorder.

How similar studies have gone: While BA has been proven effective for unipolar depression, its application in bipolar depression is less explored, making this a novel approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* scoring in the clinical range on a self-report measure of depression severity (the PHQ-9) meeting diagnostic criteria for depression based on a diagnosis on Diagnostic Interview for Anxiety, Mood, and OCD and Related Neuropsychiatric Disorders (DIAMOND)

meeting diagnostic criteria for Bipolar I or II Disorder DIAMOND) participants will require a working knowledge of written and spoken Icelandic, sufficient to make use of therapy and complete research assessments without the need for a translator.

Exclusion Criteria:

* current/past learning disability, organic brain change, substance dependence (drugs and alcohol) that would compromise the ability to use therapy
* current marked risk to self (i.e., self-harm or suicide) that we deem could not be appropriately managed in the Bipolar outpatient clinic at Landspitali.
* currently lacking the capacity to give informed consent
* currently receiving other psychosocial therapy for depression or bipolar disorder
* presence of another area of difficulty that the therapist and client believe should be the primary focus of intervention (for example, Post-Traumatic Stress Disorder, psychosis)

Where it's running

  • Landspitali university hospital
    Reykjavik, Iceland
    Recruiting

Study contacts

  • Principal investigator: Anna S Islind, PhD — Reykjavik University
  • Study coordinator: Halla Ó Ólafsdóttir, Cand. psych
  • Email: hallaosh@landspitali.is
  • Phone: 8688371

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.